الأصول تغيير تاريخ
AbbVie USD 136.46B 2.5B 2026-03
Align Technology USD 6.42B 103.41M 2026-06
Bayer EUR 107.94B 3.4B 2026-03
Bristol-Myers Squibb USD 87.63B 1.16B 2026-06
Charles River Laboratories USD 7.73B 594.89M 2026-03
Coherus Biosciences USD 258.34M 258.18M 2025-12
Dentsply International USD 5.23B 200M 2026-03
Eli Lilly USD 116.58B 4.1B 2026-03
Henry Schein USD 11.3B 89M 2026-03
Idexx Laboratories USD 3.39B 34.74M 2026-03
Illumina USD 6.65B 91M 2026-06
IQVIA Holdings USD 29.88B 206M 2026-06
J&J USD 201.06B 167M 2026-06
Laboratory Of America USD 18.53B 554.8M 2026-06
Merck USD 128.68B 8.18B 2026-03
Neogen USD 3.35B 13M 2026-03
Pacira USD 1.21B 56.38M 2026-03
Perrigo USD 7.98B 551.9M 2026-03
Pfizer USD 207.62B 542M 2026-03
Phibro Animal Health USD 1.45B 39.56M 2026-03
Quest Diagnostics USD 16.94B 266M 2026-06
Sanofi EUR 129.06B 1.04B 2026-06
Sanofi EUR 128.02B 1.22B 2026-03
Zoetis USD 15.15B 313M 2026-03